Unit 15, 4th Floor, No. 47, South Khordmand St., Tehran, Iran. |
+98 21 88309291, 88825946, 88311666
Actobiochem, a prominent subsidiary of Actover Holding, proudly participated in the International Pharmex Exhibition, one of the most significant global events in the pharmaceutical industry. This exhibition provided a unique platform to showcase advancements and innovations in Active Pharmaceutical Ingredient (API) production.
Actobiochem presented its diverse range of products in key therapeutic areas such as cardiovascular, diabetes, oncology, and hormonal medications. The company also highlighted its cutting-edge technologies for API production and established valuable connections with leading domestic and international pharmaceutical companies.
During the exhibition, Actobiochem’s management stated:
"Participating in Pharmex is an invaluable opportunity to showcase the capabilities of Iranian scientists and professionals on a global scale. At Actobiochem, we believe that adopting advanced API production technologies can play a pivotal role in enhancing the quality of Iranian medicines and achieving greater access to international markets."
Actobiochem, a distinguished subsidiary of Actover Holding, not only participated in the International Pharmex Exhibition but also proudly received a prestigious award for its outstanding contributions to the pharmaceutical industry. This recognition highlights the company’s innovative advancements in the production of Active Pharmaceutical Ingredients (API) and its commitment to excellence. The award acknowledges Actobiochem’s achievements […]
Actobiochem, a leading player in Iran’s pharmaceutical industry, organized a specialized panel on “Pharmaceutical and Medical Bioterrorism” in collaboration with health sector professionals during the Iran Health International Exhibition 2023. The event, held on May 20, 2023, aimed to address the threats posed by bioterrorism in the pharmaceutical and medical sectors and to explore the […]
Actobiochem, a subsidiary of Actover Holding, was established to produce Active Pharmaceutical Ingredients (API) and has succeeded in driving advancements in Iran’s pharmaceutical industry.
All rights reserved by Actobiochem Pharmaceutical Compony.
Leave a Reply